Lose Weight with GLP-1 Medications
FDA-approved weight loss medications like Ozempic, Wegovy, and Mounjaro. Prescribed by licensed providers with personalized support.
1 Typical results vary. In randomized controlled trials, semaglutide 2.4mg led to ~14.9% mean weight loss at 68 weeks; tirzepatide up to ~20% at 72 weeks in adults without diabetes (NEJM 2021, 2022)
* Individual results may vary. Treatment effectiveness depends on adherence, lifestyle factors, and medical history. Medication costs vary by drug and pharmacy.
FDA-Approved Weight Loss Medications
Choose from proven GLP-1 medications prescribed by licensed healthcare providers
1 Clinical Evidence: Semaglutide demonstrated 14.9% mean weight loss at 68 weeks (STEP trials, NEJM 2021). Tirzepatide showed up to 20.9% mean weight reduction at 72 weeks (SURMOUNT trials, NEJM 2022). Liraglutide achieved 8-10% mean weight loss in SCALE trials. Results based on randomized controlled trials in adults without diabetes.
* Individual results vary significantly. Weight loss depends on medication adherence, diet, exercise, baseline BMI, and medical factors. Consultation includes personalized treatment planning based on your health profile.
GLP-1 receptor agonist, weekly injection
Dual GIP/GLP-1 receptor agonist
Daily GLP-1 medication option
How It Works
Get treated in 3 simple steps
Health Assessment
Complete comprehensive health assessment including BMI calculation and medical history
Provider Review
Licensed provider reviews your information and creates personalized weight loss plan
Ongoing Support
Monthly check-ins, medication adjustments, and lifestyle coaching for optimal results
Ready to Start Your Weight Loss Journey?
Join thousands who have successfully lost weight with our medical weight loss program
Start Your Free ConsultationNo commitment required • Cancel anytime